94 related articles for article (PubMed ID: 25468260)
1. The top ten clues to understand the origin of chronic lymphocytic leukemia (CLL).
García-Muñoz R; Feliu J; Llorente L
J Autoimmun; 2015 Jan; 56():81-6. PubMed ID: 25468260
[TBL] [Abstract][Full Text] [Related]
2. Chronic lymphocytic leukaemia: could immunological tolerance mechanisms be the origin of lymphoid neoplasms?
García-Muñoz R; Llorente L
Immunology; 2014 Aug; 142(4):536-50. PubMed ID: 24645778
[TBL] [Abstract][Full Text] [Related]
3. Immunological aspects in chronic lymphocytic leukemia (CLL) development.
García-Muñoz R; Roldan Galiacho V; Llorente L
Ann Hematol; 2012 Jul; 91(7):981-96. PubMed ID: 22526361
[TBL] [Abstract][Full Text] [Related]
4. Basic biology of autoimmune phenomena in chronic lymphocytic leukemia.
Pritsch O; Maloum K; Dighiero G
Semin Oncol; 1998 Feb; 25(1):34-41. PubMed ID: 9482525
[TBL] [Abstract][Full Text] [Related]
5. From normal to clonal B cells: Chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity.
Ghia P; Scielzo C; Frenquelli M; Muzio M; Caligaris-Cappio F
Autoimmun Rev; 2007 Dec; 7(2):127-31. PubMed ID: 18035322
[TBL] [Abstract][Full Text] [Related]
6. The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia.
Stevenson FK; Forconi F; Packham G
Semin Hematol; 2014 Jul; 51(3):158-67. PubMed ID: 25048780
[TBL] [Abstract][Full Text] [Related]
7. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia.
Allsup DJ; Kamiguti AS; Lin K; Sherrington PD; Matrai Z; Slupsky JR; Cawley JC; Zuzel M
Cancer Res; 2005 Aug; 65(16):7328-37. PubMed ID: 16103084
[TBL] [Abstract][Full Text] [Related]
8. LCK is an important mediator of B-cell receptor signaling in chronic lymphocytic leukemia cells.
Talab F; Allen JC; Thompson V; Lin K; Slupsky JR
Mol Cancer Res; 2013 May; 11(5):541-54. PubMed ID: 23505068
[TBL] [Abstract][Full Text] [Related]
9. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire.
Schroeder HW; Dighiero G
Immunol Today; 1994 Jun; 15(6):288-94. PubMed ID: 7520700
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line.
Minuzzo S; Indraccolo S; Tosello V; Piovan E; Cabrelle A; Trentin L; Semenzato G; Amadori A
Br J Haematol; 2005 Sep; 130(6):878-89. PubMed ID: 16156858
[TBL] [Abstract][Full Text] [Related]
11. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
[TBL] [Abstract][Full Text] [Related]
12. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor.
Chiorazzi N; Ferrarini M
Annu Rev Immunol; 2003; 21():841-94. PubMed ID: 12615894
[TBL] [Abstract][Full Text] [Related]
13. Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy.
Hoogendoorn M; Wolbers JO; Smit WM; Schaafsma MR; Barge RM; Willemze R; Falkenburg JH
Leukemia; 2004 Jul; 18(7):1278-87. PubMed ID: 15116118
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells.
Suljagic M; Laurenti L; Tarnani M; Alam M; Malek SN; Efremov DG
Leukemia; 2010 Dec; 24(12):2063-71. PubMed ID: 20861921
[TBL] [Abstract][Full Text] [Related]
15. Antigens in chronic lymphocytic leukemia--implications for cell origin and leukemogenesis.
Rosén A; Murray F; Evaldsson C; Rosenquist R
Semin Cancer Biol; 2010 Dec; 20(6):400-9. PubMed ID: 20863893
[TBL] [Abstract][Full Text] [Related]
16. Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia.
Kikushige Y; Ishikawa F; Miyamoto T; Shima T; Urata S; Yoshimoto G; Mori Y; Iino T; Yamauchi T; Eto T; Niiro H; Iwasaki H; Takenaka K; Akashi K
Cancer Cell; 2011 Aug; 20(2):246-59. PubMed ID: 21840488
[TBL] [Abstract][Full Text] [Related]
17. Signaling pathways activated by the B-cell receptor in chronic lymphocytic leukemia.
Scupoli MT; Pizzolo G
Expert Rev Hematol; 2012 Jun; 5(3):341-8. PubMed ID: 22780213
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease.
Vlad A; Deglesne PA; Letestu R; Saint-Georges S; Chevallier N; Baran-Marszak F; Varin-Blank N; Ajchenbaum-Cymbalista F; Ledoux D
Cancer Res; 2009 Aug; 69(16):6387-95. PubMed ID: 19654311
[TBL] [Abstract][Full Text] [Related]
19. New insights into the pathogenesis of chronic lymphocytic leukemia.
Klein U; Dalla-Favera R
Semin Cancer Biol; 2010 Dec; 20(6):377-83. PubMed ID: 21029776
[TBL] [Abstract][Full Text] [Related]
20. B-cell chronic lymphocytic leukemia-derived dendritic cells stimulate allogeneic T-cell response and express chemokines involved in T-cell migration.
Łuczyński W; Stasiak-Barmuta A; Piszcz J; Iłendo E; Kowalczuk O; Krawczuk-Rybak M
Neoplasma; 2007; 54(6):527-35. PubMed ID: 17949237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
